How ME/CFS Is Diagnosed Today – and Why It Often Takes So Long to Get There

For many people with ME/CFS, their medical story doesn't begin with a diagnosis, but with a long path towards one: countless doctor's appointments, shifting suspected diagnoses, sometimes even doubts about their own experience. This is exhausting – and there are solid medical reasons behind it. This article explains the criteria used to diagnose ME/CFS today, what the typical path to diagnosis looks like, and why it so often takes a long time. It does not replace a medical examination, but aims to help put the process into perspective.

Why there is no simple test

One of the central difficulties: there is still no single laboratory or imaging test that can definitively confirm ME/CFS. The diagnosis is a clinical assessment based on medical history, physical examination, and the exclusion of other conditions. However, experts increasingly emphasise that ME/CFS is nonetheless not a purely "diagnosis of exclusion" in the classic sense – rather, it is diagnosed on the basis of positive, clearly defined symptom criteria, while other possible causes are investigated in parallel.

The criteria: what counts as the standard today

Internationally, two sets of criteria have become established in particular. In the US, the CDC recommends the Institute of Medicine (IOM) criteria from 2015. According to these, all of the following core symptoms must be present:

• A substantial reduction in activity lasting at least six months compared to the person's condition before falling ill, accompanied by often pronounced fatigue that cannot be explained by excessive exertion and does not significantly improve with rest
• Post-exertional malaise (PEM) – a delayed worsening following physical, mental, or even orthostatic exertion
• Unrefreshing sleep
• At least one of two further symptoms: cognitive impairment or orthostatic intolerance

In the UK, the National Institute for Health and Care Excellence (NICE) published a revised guideline in 2021. It explicitly recognises PEM as a core symptom and allows a diagnosis to be made after just three months of persistent symptoms rather than six, in order to enable earlier support. Both approaches agree that PEM is now regarded as one of the most important distinguishing features of ME/CFS – unlike older, broader criteria such as the Fukuda criteria from the 1990s, which did not necessarily require PEM.

The typical path to diagnosis

In practice, the diagnostic process usually unfolds in several steps. First, a detailed medical history is taken: when did the symptoms begin, was there a trigger such as an infection, how does the condition change after exertion? Doctors may ask patients to keep a diary of activities and symptoms over several weeks in order to better capture PEM – since the crash often occurs with a delay and can therefore easily be overlooked.

At the same time, a basic set of tests is carried out to rule out or identify other causes for the symptoms. These usually include a full blood count, thyroid levels, inflammation markers, as well as further targeted tests depending on the symptom picture, for example to check for autoimmune diseases, sleep disorders, hormonal causes, or other internal medicine and neurological conditions. It's important to know that even if another condition is found, this does not automatically rule out ME/CFS – dual diagnoses do occur.

Since the criteria require a minimum window of three to six months of persistent symptoms, the final diagnosis is often only made after a certain observation period. During this phase, treating doctors may already keep ME/CFS in mind as a suspected diagnosis and offer initial recommendations on managing exertion limits, even before all criteria are formally met.

Why diagnosis often takes so long

For many people affected, reality looks considerably more protracted than the ideal path described above. In surveys, 67 to 77 percent of patients reported that diagnosis took longer than a year, and around 29 percent waited five years or longer. Estimates suggest that a large proportion of those affected remain undiagnosed to this day.

Several factors contribute to this: for one, the lack of a confirmatory test is in itself already a hurdle. For another, ME/CFS remains underrepresented in medical education – only a small part of medical curricula covers the condition in depth, leading to limited familiarity in everyday clinical practice. In addition, symptoms such as fatigue or sleep problems are non-specific and can easily be mistaken for other, more common conditions or – particularly in women – prematurely attributed to psychological causes. Structural factors such as unequal access to specialised care also play a role: studies point, for instance, to differences in diagnosis rates depending on background and access to healthcare.

Experts emphasise that earlier diagnosis would be important, because timely information on managing exertion limits may help prevent further deterioration. This is precisely why it is worth actively raising the issue in cases of persistent, unexplained fatigue that worsens after exertion, and, if necessary, seeking a second medical opinion or a specialised clinic.

What this means for everyday life

A pending or still uncertain diagnosis does not mean that one's own experiences are any less real or any less worthy of being taken seriously. Many people affected report that simply knowing about PEM and the importance of recovery periods is already helpful for managing daily life more carefully, even before a formal diagnosis. mypacing can help make one's own patterns of exertion and recovery, in the sense of pacing, visible – but it does not replace medical evaluation. The final assessment of symptoms always belongs in the hands of a doctor, ideally one specialised in ME/CFS.

Sources

• Diagnosing ME/CFS
• Symptoms of ME/CFS
• Overview | Myalgic encephalomyelitis (or encephalopathy)/chronic fatigue syndrome: diagnosis and management | NICE guideline NG206
• Diagnosis and Management of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
• Beyond Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (Summary)
• Understanding symptom clusters, diagnosis and healthcare experiences in myalgic encephalomyelitis/chronic fatigue syndrome and long COVID: a cross-sectional survey in the UK